New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder -November 24, 2023 at 08:56 am EST

TEL AVIV, Israel, Nov. 24, 2023 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare disease of the central...

Related Keywords

Israel ,Oz Adler ,National Autism Research Center ,Nasdaq ,Exchange Commission ,Soroka Medical Center ,Company Or Scisparc ,Scisparc Ltd ,Autism Spectrum Disorder ,Chief Executive Officer ,Tourette Syndrome ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,